Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
2.670
-0.550 (-17.08%)
At close: Aug 19, 2026, 4:00 PM EDT
2.770
+0.100 (3.75%)
After-hours: Aug 19, 2026, 7:59 PM EDT
Intelligent Bio Solutions Revenue
In the fiscal year ending June 30, 2026, Intelligent Bio Solutions had annual revenue of $4.22M with 38.09% growth. Intelligent Bio Solutions had revenue of $1.15M in the quarter ending June 30, 2026, with 35.78% growth.
Revenue (ttm)
$4.22M
Revenue Growth
+38.09%
P/S Ratio
1.52
Revenue / Employee
$76,640
Employees
55
Market Cap
6.39M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 4.22M | 1.16M | 38.09% |
| Jun 30, 2025 | 3.05M | -59.25K | -1.90% |
| Jun 30, 2024 | 3.11M | 1.85M | 147.58% |
| Jun 30, 2023 | 1.26M | 819.73K | 187.52% |
| Jun 30, 2022 | 437.15K | -1.54M | -77.93% |
| Jun 30, 2021 | 1.98M | 1.79M | 949.30% |
| Jun 30, 2020 | 188.74K | - | - |
| Jun 30, 2019 | - | - | - |
| Jun 30, 2018 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 43.79M |
| WORK Medical Technology Group LTD | 10.72M |
| Picard Medical | 5.47M |
| Biomerica | 4.33M |
| IceCure Medical | 3.95M |
| Sintx Technologies | 1.33M |
| Co-Diagnostics | 721.39K |
| Nexalin Technology | 217.16K |
INBS News
- 19 hours ago - Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth - GlobeNewsWire
- 20 hours ago - Intelligent Bio Solutions Annual report: Q4 2026 - Filings
- 20 hours ago - Intelligent Bio Solutions Earnings release: Q4 2026 - Filings
- 2 days ago - Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification - GlobeNewsWire
- 8 days ago - Intelligent Bio Solutions completes fingerprint drug screening study - TheFly
- 8 days ago - Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System - GlobeNewsWire
- 14 days ago - Intelligent Bio Solutions Completes Usability Study Supporting FDA 510(k) Submission - GlobeNewsWire
- 16 days ago - Intelligent Bio Solutions Completes Interference Study Examining the Impact of Everyday Substances on Intelligent Fingerprinting System - GlobeNewsWire